Annual CFF
$2.25 M
-$130.02 M-98.30%
December 31, 2023
Summary
- As of February 7, 2025, ADPT annual cash flow from financing activities is $2.25 million, with the most recent change of -$130.02 million (-98.30%) on December 31, 2023.
- During the last 3 years, ADPT annual CFF has fallen by -$291.34 million (-99.24%).
- ADPT annual CFF is now -99.30% below its all-time high of $319.92 million, reached on December 31, 2019.
Performance
ADPT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$40.00 K
+$10.00 K+33.33%
September 30, 2024
Summary
- As of February 7, 2025, ADPT quarterly cash flow from financing activities is $40.00 thousand, with the most recent change of +$10.00 thousand (+33.33%) on September 30, 2024.
- Over the past year, ADPT quarterly CFF has dropped by -$47.00 thousand (-54.02%).
- ADPT quarterly CFF is now -99.99% below its all-time high of $319.55 million, reached on September 30, 2019.
Performance
ADPT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$201.00 K
+$23.00 K+12.92%
September 30, 2024
Summary
- As of February 7, 2025, ADPT TTM cash flow from financing activities is $201.00 thousand, with the most recent change of +$23.00 thousand (+12.92%) on September 30, 2024.
- Over the past year, ADPT TTM CFF has dropped by -$2.04 million (-91.05%).
- ADPT TTM CFF is now -99.94% below its all-time high of $332.59 million, reached on June 30, 2020.
Performance
ADPT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ADPT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -98.3% | -54.0% | -91.0% |
| 3 y3 years | -99.2% | -99.0% | -98.5% |
| 5 y5 years | +79.9% | -99.0% | -98.5% |
ADPT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.3% | at low | -100.0% | +566.7% | -99.8% | +12.9% |
| 5 y | 5-year | -99.3% | at low | -100.0% | +566.7% | -99.9% | +12.9% |
| alltime | all time | -99.3% | +79.9% | -100.0% | +102.7% | -99.9% | +119.2% |
Adaptive Biotechnologies Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $40.00 K(+33.3%) | $201.00 K(+12.9%) |
| Jun 2024 | - | $30.00 K(-31.8%) | $178.00 K(-89.0%) |
| Mar 2024 | - | $44.00 K(-49.4%) | $1.62 M(-28.0%) |
| Dec 2023 | $2.25 M(-98.3%) | $87.00 K(+411.8%) | $2.25 M(+3.7%) |
| Sep 2023 | - | $17.00 K(-98.8%) | $2.16 M(-98.3%) |
| Jun 2023 | - | $1.47 M(+118.6%) | $127.67 M(-1.9%) |
| Mar 2023 | - | $672.00 K(>+9900.0%) | $130.19 M(-1.6%) |
| Dec 2022 | $132.26 M(+387.2%) | $6000.00(-100.0%) | $132.26 M(-2.4%) |
| Sep 2022 | - | $125.52 M(+3045.9%) | $135.54 M(+947.2%) |
| Jun 2022 | - | $3.99 M(+45.1%) | $12.94 M(-15.3%) |
| Mar 2022 | - | $2.75 M(-16.1%) | $15.28 M(-43.7%) |
| Dec 2021 | $27.15 M | $3.28 M(+12.0%) | $27.15 M(-9.9%) |
| Sep 2021 | - | $2.93 M(-53.8%) | $30.12 M(-90.1%) |
| Jun 2021 | - | $6.33 M(-56.7%) | $303.23 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $14.61 M(+133.7%) | $303.24 M(+3.3%) |
| Dec 2020 | $293.59 M(-8.2%) | $6.25 M(-97.7%) | $293.59 M(+1.6%) |
| Sep 2020 | - | $276.04 M(+4256.0%) | $289.08 M(-13.1%) |
| Jun 2020 | - | $6.34 M(+27.8%) | $332.59 M(+2.4%) |
| Mar 2020 | - | $4.96 M(+184.0%) | $324.75 M(+1.5%) |
| Dec 2019 | $319.92 M(>+9900.0%) | $1.75 M(-99.5%) | $319.92 M(+0.5%) |
| Sep 2019 | - | $319.55 M(<-9900.0%) | $318.45 M(<-9900.0%) |
| Jun 2019 | - | -$1.50 M(-1312.9%) | -$1.04 M(-215.5%) |
| Mar 2019 | - | $124.00 K(-55.4%) | $905.00 K(-27.5%) |
| Dec 2018 | $1.25 M(-97.5%) | $278.00 K(+387.7%) | $1.25 M(+28.7%) |
| Sep 2018 | - | $57.00 K(-87.2%) | $970.00 K(+6.2%) |
| Jun 2018 | - | $446.00 K(-4.5%) | $913.00 K(+95.5%) |
| Mar 2018 | - | $467.00 K | $467.00 K |
| Dec 2017 | $50.03 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual cash flow from financing activities?
- What is the all time high annual CFF for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual CFF year-on-year change?
- What is Adaptive Biotechnologies quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly CFF year-on-year change?
- What is Adaptive Biotechnologies TTM cash flow from financing activities?
- What is the all time high TTM CFF for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM CFF year-on-year change?
What is Adaptive Biotechnologies annual cash flow from financing activities?
The current annual CFF of ADPT is $2.25 M
What is the all time high annual CFF for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual cash flow from financing activities is $319.92 M
What is Adaptive Biotechnologies annual CFF year-on-year change?
Over the past year, ADPT annual cash flow from financing activities has changed by -$130.02 M (-98.30%)
What is Adaptive Biotechnologies quarterly cash flow from financing activities?
The current quarterly CFF of ADPT is $40.00 K
What is the all time high quarterly CFF for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly cash flow from financing activities is $319.55 M
What is Adaptive Biotechnologies quarterly CFF year-on-year change?
Over the past year, ADPT quarterly cash flow from financing activities has changed by -$47.00 K (-54.02%)
What is Adaptive Biotechnologies TTM cash flow from financing activities?
The current TTM CFF of ADPT is $201.00 K
What is the all time high TTM CFF for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM cash flow from financing activities is $332.59 M
What is Adaptive Biotechnologies TTM CFF year-on-year change?
Over the past year, ADPT TTM cash flow from financing activities has changed by -$2.04 M (-91.05%)